Reprogrammed Lipid Metabolism as a Gatekeeper of Hepatocarcinogenesis: from Enzyme Regulation to Precision Therapy.
APA
Yang L, Yang J, et al. (2026). Reprogrammed Lipid Metabolism as a Gatekeeper of Hepatocarcinogenesis: from Enzyme Regulation to Precision Therapy.. Current oncology reports, 28(1), 8. https://doi.org/10.1007/s11912-026-01741-2
MLA
Yang L, et al.. "Reprogrammed Lipid Metabolism as a Gatekeeper of Hepatocarcinogenesis: from Enzyme Regulation to Precision Therapy.." Current oncology reports, vol. 28, no. 1, 2026, pp. 8.
PMID
41642507
같은 제1저자의 인용 많은 논문 (5)
- Generational trends in reproductive factors among women in the US: implications for breast cancer incidence.
- Prediction of high-risk factor in early-stage lung cancer: micropapillary adenocarcinoma.
- Comprehensive treatment for intracranial invasive sinonasal intestinal-type adenocarcinoma with a focus on radiotherapy dosage and immunological combination therapy: A case report.
- Cancer-associated fibroblasts-derived exosomes in colorectal cancer progression: Mechanism and therapeutic opportunities.
- Effects of Preoperative Mindfulness Training Combined With Active Breathing and Circulation Exercises on Pulmonary Function Recovery in Lung Cancer Patients After Lobectomy.